Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein

Vaccine

Volumn 28, Issue 32, 2010, Pages 5237-5244

  Shi, Chunwei ^a   Chen, Lingxia ^a   Chen, Zhenhua ^a   Zhang, Ying ^b   Zhou, Zhiguang ^a   Lu, Jia ^a   Fu, Ruiling ^a   Wang, Chun ^a   Fang, Zhengming ^a   Fan, Xionglin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HspX; Latency antigen; Recombinant BCG; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; RECOMBINANT BCG HEAT SHOCK PROTEIN X VACCINE; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ANTIGEN 85B, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; HSPX PROTEIN, MYCOBACTERIUM TUBERCULOSIS; IMMUNOGLOBULIN G; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TUBERCULOSIS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; GERMFREE ANIMAL; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOLOGY;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUBERCULOSIS; VACCINES, SYNTHETIC;

EID: 77954956888     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.063     Document Type: Article

References (42)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006, 367:938-940.
2. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163:1009-1021.
3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994, 271:698-702.
4. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
5. Finan C., Ota M.O.C., Marchant A., Newport M.J. Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccination in a cohort of Gambian infants. PLoS ONE 2008, 3:e3485.
6. Vekemans J., Ota M.O., Sillah J., Fielding K., Alderson M.R., Skeiky Y.A., et al. Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design. Infect Immun 2004, 72:381-388.
7. Coler R.N., Campos-Neto A., Ovendale P., Day F.H., Fling S.P., Zhu L., et al. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 2001, 166:6227-6235.
8. Hoft D.F., Blazevic A., Abate G., Hanekom W.A., Kaplan G., Soler J.H., et al. A new recombinant Bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 2008, 198:1491-1501.
9. Khera A., Singh R., Shakila H., Raoa V., Dhar N., Narayanan P.R., et al. Elicitation of efficient protective immune responses by using DNA vaccines against tuberculosis. Vaccine 2005, 23:5655-5665.
10. McShane H., Pathan A.A., Sander C.R., Keating S.M., Gilbert S.C., Huygen K., et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004, 10:1240-1244.
11. Reed S.G., Coler R.N., Dalemans W., Tan E.V., DeLa Cruz E.C., Basaraba R.J., et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 2009, 106:2301-2306.
12. Boon C., Li R., Qi R., Dick T. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J Bacteriol 2001, 183:2672-2676.
13. Cunningham A.F., Spreadbury C.L. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 1998, 180:801-808.
14. Lim A., Eleuterio M., Hutter B., Murugasu-Oei B., Dick T. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J Bacteriol 1999, 181:2252-2256.
15. Monahan I.M., Betts J., Banerjee D.K., Butcher P.D. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 2001, 147:459-471.
16. Geluk A., Lin M.Y., van Meijgaarden K.E., Leyten E.M.S., Franken K.L.M.C., Ottenhoff T.H.M., et al. T-Cell Recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect Immun 2007, 75:2914-2921.
17. Lin M.Y., Geluk A., Smith S.G., Stewart A.L., Friggen A.H., Franken K.L.M.C., et al. Lack of immune responses to Mycobacterium tuberculosis dosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun 2007, 75:3523-3530.
18. Wayne L.G., Hayes L.G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996, 64:2062-2069.
19. Yuan Y., Crane D.D., Simpson R.M., Zhu Y.Q., Hickey M.J., Sherman D.R., et al. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 1998, 95:9578-9583.
20. Caccamoa N., Milano S., Di Sano C., Cigna D., Ivanyi J., Krensky A.M., et al. Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8+ T lymphocytes. J Infect Dis 2002, 186:991-998.
21. Wilkinson R.J., Wilkinson K.A., De Smet K.A., Haslov K., Pasvol G., Singh M., et al. Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol 1998, 48:403-409.
22. Caccamoa N., Meravigliaa S., Dielia F., Romanob A., Titoneb L., Salernoa A. Th0 to Th1 switch of CD4 T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successful therapy: lack of involvement of epitope repertoire and LA-DR. Immunol Lett 2005, 98:253-258.
23. Roupie V., Romano M., Zhang L., Korf H., Lin M.Y., Franken K.L.M.C., et al. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun 2007, 75:941-949.
24. Fu R., Wang C., Shi C., Lu M., Fang Z., Lu J., et al. An improved whole blood interferon-gamma assay based on the CFP21-MPT64 fusion protein. Clin Vaccine Immunol 2009, 16:686-691.
25. Dormans J., Burger M., Aguilar D., Hernandez-Pando R., Kremer K., Roholl P., et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 2004, 137:460-468.
26. Yuan Y, Crane D.D., Barry C.E. Stationary phase associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial a-crystallin homolog. J Bacteriol 1996, 178:4484-4492.
27. Silva V.M.C., Kanaujia G., Gennaro M.L., Menzies D. Factors associated with humoral response to ESAT-6, 38kDa and 14kDa in patients with a spectrum of tuberculosis. Int J Tuberc Lung Dis 2003, 7:478-484.
28. Demissie A., Leyten E.M., Abebe M., Wassie L., Aseffa A., Abate G., et al. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol 2006, 13:179-186.
29. Davidow A., Kanaujia G.V., Shi L., Kaviar J., Guo X., Sung N., et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun 2005, 73:6846-6851.
30. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997, 276:1420-1422.
31. Horwitz M.A., Harth G., Dillon B.J., Maslesa-Galic' S. Recombinant Bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000, 97:13853-13858.
32. Jain R., Dey B., Dhar N., Rao V., Singh R., Gupta U.D., et al. Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS ONE 2008, 3:e3869.
33. Sugawara I., Li Z., Sun L., Udagawa T., Taniyama T. Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007, 87:518-525.
34. Castanñon-Arreolaa M., Loópez-Vidala Y., Espitia-Pinzoónb C., Hernaóndez-Pandoc R. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Tuberculosis 2005, 85:115-126.
35. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9:533-539.
36. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980, 20:1-63.
37. Boon C., Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 2002, 184:6760-6767.
38. Park H.D., Guinn K.M., Harrell M.I., Liao R., Voskuil M.I., Tompa M., et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003, 48:833-843.
39. Rosenkrands I., Slayden R.A., Crawford J., Aagaard C., Barry C.E., Andersen P. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 2002, 184:3485-3491.
40. Sherman D.R., Voskuil M., Schnappinger D., Liao R., Harrell M.I., Schoolnik G.K. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci USA 2001, 98:7534-7539.
41. Florczyk M.A., McCue L.A., Stack R.F., Hauer C.R., McDonough K.A. Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect Immun 2001, 69:5777-5785.
42. Leyten E.M., Lin M.Y., Franken K.L., Friggen A.H., Prins C., van Meijgaarden K.E., et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 2006, 8:2052-2060.